HOME › DRUGS › DELGOCITINIB
ACTIVE SUBSTANCE / INN

DELGOCITINIB

Brand name(s): Anzupgo, ANZUPGO
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Dermatitis;Eczema
NDA219155
ACTIVE SUBSTANCE
Delgocitinib
REGULATORS
FDA · EMA
SPONSORS / MAH
LEO Pharma A/S, LEO PHARMA AS
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ANZUPGONDA219155LEO PHARMA ASPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AnzupgoLEO Pharma A/SAuthorised19/09/2024Dermatitis;Eczema

FULL INTELLIGENCE ON DELGOCITINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →